The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials*
Abstract
OBJECTIVE: To determine the effect of albumin administration on morbidity in acutely ill hospitalized patients. DATA SOURCE: Computer searches of MEDLINE, EMBASE, and the Cochrane Library; hand searches of journals and Index Medicus; inquiries with investigators and fluid product suppliers; and examination of reference lists. No language or time period restrictions were adopted. STUDY SELECTION: Randomized, controlled trials comparing the administration of albumin with that of crystalloid, no albumin, or lower-dose albumin. DATA EXTRACTION: Two investigators independently extracted data. The primary endpoint for the meta-analysis was morbidity, defined as the incidence of complications, including death. Trial quality was evaluated by blinding, allocation concealment, presence of morbidity as a study endpoint, and individual patient crossover. DATA SYNTHESIS: Seventy-one trials were included in the categories of surgery or trauma, burns, hypoalbuminemia, high-risk neonates, ascites, and other indications. The 3,782 randomized patients in the included trials experienced a total of 3,287 complications, including 515 deaths and 2,772 cardiovascular, gastrointestinal, hepatic, infectious, renal, respiratory, and other complications. Albumin significantly reduced overall morbidity, with a risk ratio of 0.92 (confidence interval [CI], 0.86-0.98). Control group albumin dose significantly affected the incidence of complications (p = .002). In 32 trials with no albumin administered to the control group, the risk ratio was 0.77 (CI, 0.67-0.88) compared with 0.89 (CI, 0.80-1.00) in 20 trials with control patients receiving low-dose albumin and 1.07 (CI, 0.96-1.20) in 19 trials with moderate-dose control group albumin. CONCLUSIONS: Albumin reduces morbidity in acutely ill hospitalized patients. Concomitant administration of albumin in the control group can obscure the effects of albumin on clinical outcome in randomized trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
Wilkes, M. M., & Navickis, R. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-3-200108070-00007 · Cited by 486
Self-citationInvited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies
Berlin, J. A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117645 · Cited by 191
Cited by
Specific antioxidant properties of human serum albumin
Taverna, M., Marie, A.-L., Mira, J.-P., & Guidet, B. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-4 · Cited by 473
Gatta, A., Verardo, A., & Bolognesi, M. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0802-0 · Cited by 456
Vincent, J.-L., & Weil, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000214677.76535.a5 · Cited by 424
Self-citationPatel, A., Laffan, M. A., Waheed, U., & Brett, S. J. (2014) · BMJ · doi:10.1136/bmj.g4561 · Cited by 291
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients
Reinhart, K., Perner, A., Sprung, C. L., Jaeschke, R., Schortgen, F., Johan Groeneveld, A. B., Beale, R., & Hartog, C. S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2472-9 · Cited by 282
Metadata
- Authors
- Vincent, J.-L., Navickis, R. J., & Wilkes, M. M.
- Venue
- Critical Care Medicine
- Published
- 2004-10
- Volume
- 32
- Issue
- 10
- Pages
- 2029-2038
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2036290945
- Cited by
- 185
- References
- 4
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials*. https://app.cochat.ai/papers/10.1097/01.ccm.0000142574.00425.e9
- The paper
- Vincent, J.-L., Navickis, R. J., & Wilkes, M. M. (2004). Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000142574.00425.e9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.